According to a report, around 54% of people whove used GLP-1s said the medication was hard to afford, even with insurance
Who should NOT use a GLP1 medication for weight loss
Misleading ad pricing, costs buried in FAQ, unverifiable media endorsements, vague backed by science claims, AI-looking website images, checkout countdown timers, and zero disclosure about oral versus injectable medication differences all create a trust deficit that the strong clinical legitimacy just cannot fully offset
This matches the clinical trial inclusion criteria, which recruited obese subjects
Treatment resulted in increased hippocampal acetylcholinesterase activity and dendritic arborization of hippocampal CA3 neurons
Disorders of gastric accommodation are typically associated with postprandial distress syndrome, a component of functional dyspepsia